Induced gene expression of the hypusine-containing protein eukaryotic initiation factor 5A in activated human T lymphocytes
- PMID: 7971969
- PMCID: PMC45119
- DOI: 10.1073/pnas.91.23.10829
Induced gene expression of the hypusine-containing protein eukaryotic initiation factor 5A in activated human T lymphocytes
Abstract
The hypusine-containing protein eukaryotic initiation factor 5A (eIF-5A) is a cellular cofactor critically required for the function of the Rev transactivator protein of human immunodeficiency virus type 1 (HIV-1). eIF-5A localizes in the nuclear and cytoplasmic compartments of mammalian cells, suggesting possible activities on the level of regulated mRNA transport and/or protein translation. In this report we show that eIF-5A gene expression is constitutively low but inducible with T-lymphocyte-specific stimuli in human peripheral blood mononuclear cells (PBMCs) of healthy individuals. In contrast, eIF-5A is constitutively expressed at high levels in human cell lines as well as in various human organs. Comparison of eIF-5A levels in the PBMCs of uninfected and HIV-1-infected donors shows a significant upregulation of eIF-5A gene expression in the PBMCs of HIV-1 patients, compatible with a possible role of eIF-5A in HIV-1 replication during T-cell activation.
Similar articles
-
Interaction of eukaryotic initiation factor 5A with the human immunodeficiency virus type 1 Rev response element RNA and U6 snRNA requires deoxyhypusine or hypusine modification.Biol Signals. 1997 May-Jun;6(3):166-74. doi: 10.1159/000109123. Biol Signals. 1997. PMID: 9285100
-
Hypusine: its post-translational formation in eukaryotic initiation factor 5A and its potential role in cellular regulation.Biofactors. 1993 May;4(2):95-104. Biofactors. 1993. PMID: 8347280 Review.
-
Inhibition of HIV-1 replication in lymphocytes by mutants of the Rev cofactor eIF-5A.Science. 1996 Mar 29;271(5257):1858-60. doi: 10.1126/science.271.5257.1858. Science. 1996. PMID: 8596953
-
Eukaryotic initiation factor 5A is a cellular target of the human immunodeficiency virus type 1 Rev activation domain mediating trans-activation.J Cell Biol. 1993 Dec;123(6 Pt 1):1309-20. doi: 10.1083/jcb.123.6.1309. J Cell Biol. 1993. PMID: 8253832 Free PMC article.
-
Eukaryotic initiation factor 5A activity and HIV-1 Rev function.Biol Signals. 1997 May-Jun;6(3):124-33. doi: 10.1159/000109118. Biol Signals. 1997. PMID: 9285095 Review.
Cited by
-
The polyamine-derived amino acid hypusine: its post-translational formation in eIF-5A and its role in cell proliferation.Amino Acids. 1996 Jun;10(2):109-21. doi: 10.1007/BF00806584. Amino Acids. 1996. PMID: 24178473
-
Overexpression of eukaryotic initiation factor 5A (eIF5A) affects susceptibility to benznidazole in Trypanosoma cruzi populations.Mem Inst Oswaldo Cruz. 2018 Jul 26;113(9):e180162. doi: 10.1590/0074-02760180162. Mem Inst Oswaldo Cruz. 2018. PMID: 30066751 Free PMC article.
-
Upregulation of a novel eukaryotic translation initiation factor 5A (eIF5A) in dengue 2 virus-infected mosquito cells.Virol J. 2010 Sep 7;7:214. doi: 10.1186/1743-422X-7-214. Virol J. 2010. PMID: 20819232 Free PMC article.
-
Crystal structures of eukaryotic translation initiation factor 5A from Methanococcus jannaschii at 1.8 A resolution.Proc Natl Acad Sci U S A. 1998 Sep 1;95(18):10419-24. doi: 10.1073/pnas.95.18.10419. Proc Natl Acad Sci U S A. 1998. PMID: 9724718 Free PMC article.
-
Drug-Based Lead Discovery: The Novel Ablative Antiretroviral Profile of Deferiprone in HIV-1-Infected Cells and in HIV-Infected Treatment-Naive Subjects of a Double-Blind, Placebo-Controlled, Randomized Exploratory Trial.PLoS One. 2016 May 18;11(5):e0154842. doi: 10.1371/journal.pone.0154842. eCollection 2016. PLoS One. 2016. PMID: 27191165 Free PMC article. Clinical Trial.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources